Vanguard
http://www.vanguard.com/Vanguard, an investment management company, offers mutual funds and other financial products and services to institutional and individual investors worldwide.
-
Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test
-
Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
-
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test
-
Guardant Health (GH) Granted FDA Breakthrough Device Designation for Multi-Cancer Detection (MCD) Test
-
FDA Grants Breakthrough Device Designation to Guardant Health’s Shield Multi-Cancer Detection (MCD) Test
-
Guardant Health (GH) PT Raised to $57 at Scotiabank
-
Guardant Health (GH) Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types
-
Guardant Health Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types
-
Guardant Health to Present Data Highlighting Advances in Multi-Cancer Detection and Liquid and Tissue Molecular Profiling at AACR
-
Guardant Health Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
-
Jefferies Reiterates Buy Rating on Guardant Health (GH)
-
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
-
Form SC 13G/A Guardant Health, Inc. Filed by: VANGUARD GROUP INC
-
Form SC 13G/A Guardant Health, Inc. Filed by: VANGUARD GROUP INC
-
Form SC 13G/A Guardant Health, Inc. Filed by: VANGUARD GROUP INC
-
Form SC 13G Guardant Health, Inc. Filed by: VANGUARD GROUP INC

